Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses. (Q43971695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

10

Julianna Lisziewicz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

author name string

Franco Lori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Andrea Foli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Renato Maserati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Jianqing Xu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Lucia Whitman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Elisabetta Ravot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Francesco Alberici

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Lucia Lopalco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

115-124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Latent reservoirs of HIV: obstacles to the eradication of virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Immune Restoration by Combination of a Cytostatic Drug (Hydroxyurea) and Anti-HIV Drugs (Didanosine and Indinavir)

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FVFRX-6T7X-UQ2W-V0LK

10.1310/VFRX-6T7X-UQ2W-V0LK

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11976989%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference